BIOSTROKE offers a unique platform to advance biomarker science in stroke care and foster interdisciplinary collaboration between experts in stroke biomarker research, cardiovascular medicine, and neuroscience. Bringing together 120 participants, the meeting will facilitate in-depth scientific exchange on the most pressing, unsolved challenges in clinical decision-making with sessions across the stroke care continuum – from acute management to secondary prevention and long-term recovery. The program features talks by internationally recognized leaders, alongside presentations selected from submitted abstracts. The format prioritizes open discussion and informal interactions among scientists of all career levels.
Endorsement by the European Stroke Organisation (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) as well as CME/CPD accreditation are currently in process.
More information here.